Newsfeed : U.S. Strains to Control Rising PEPFAR Costs

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Newsfeed » April 2010

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

April 14, 2010

U.S. Strains to Control Rising PEPFAR Costs

U.S. officials have asked some overseas AIDS clinics to cease new patient enrollment in antiretroviral drug programs funded through the President’s Emergency Plan for AIDS Relief (PEPFAR), according to doctors and official correspondence as reported by The Boston Globe.

AIDS advocates fear President Barack Obama’s administration is scaling back PEPFAR, the most comprehensive U.S. foreign assistance program dedicated to a single disease. President George W. Bush launched the program in 2003.

According to the article, PEPFAR’s cost grew from $2.3 billion in 2004 to nearly $7 billion this year. Currently, 2.4 million HIV-positive people around the globe—most of whom are in sub-Saharan Africa—receive lifesaving medication through the program.

“People are struggling to find resources to honor the commitments we have made,’’ said U.S global AIDS coordinator Eric Goosby. “We’re not at a cap point yet. If it gets worse, we’ll have another discussion.’

Some AIDS clinics in Africa say they are already beginning to feel the cost-cutting effects. “Virtually every day, we have to turn away patients who need treatment, including breast-feeding women,” said Peter Mugyenyi, MD, a prominent AIDS specialist in Uganda. “We have to tell them, ‘There is a freeze.’”

Search: HIV/AIDS, clinics, Africa, PEPFAR, President Barack Obama, antiretroviral drug, Uganda, funding,


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (1 total)

 
[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Have you ever been diagnosed with diabetes or pre-diabetes?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.